Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
BMC Immunology|July 7, 2024
Gut microbiota regulation of T lymphocyte subsets during systemic lupus erythematosusFen-Ping Lian, Fen Zhang, Chun-Miao Zhao, et al.
Bioorganic Chemistry|December 19, 2025
Discovery of novel cycloalkyl-fused thiazole-based pyrimidine derivatives as highly potent CDK2 inhibitors with promising antitumor activityWen-Ming Tan, Yu Fu, Jun-Wei Chen, et al.
Journal of Gastroenterology|December 3, 2005
Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative studyMing-De Lu, Hui-Xiong Xu, Xiao-Yan Xie, et al.
American Journal of Translational Research|April 10, 2020
Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasisQu Lin, Chu-Ren Zhou, Ming-Jun Bai, et al.
Immunity, Inflammation and Disease|October 31, 2023
Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancyFen Zhang, Bing-Ying Zhang, Ru Fan, et al.
BMC Medical Genomics|August 19, 2024
The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysisJia-Lin Wu, Jun-Wei Chen, Ming-Sheng Huang, et al.
World Journal of Gastroenterology|June 22, 2023
Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapyJia-Lin Wu, Jun-Yang Luo, Zai-Bo Jiang, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 29, 2026
Changes in tomographic parameters across different wearing and cessation periods of apical clearance-fitted rigid gas-permeable contact lenses in keratoconusFang-Chi Hsiao, Yen-Ning Chen, Jun-Wei Chen, et al.
Genomics|January 15, 2022
DNA N6-methyladenine involvement and regulation of hepatocellular carcinoma developmentQu Lin, Jun-Wei Chen, Hao Yin, et al.
Journal of Medicinal Chemistry|December 5, 2024
Discovery and Optimization of Dihydroquinolin-2(1<i>H</i>)-ones as Novel Highly Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial HypertensionBei Zhang, Zhong-Kai Zou, Jian-Fan Cai, et al.
Pageof 6